BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16231369)

  • 1. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.
    Uehara H; Miyamoto M; Kato K; Cho Y; Kurokawa T; Murakami S; Fukunaga A; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
    J Surg Oncol; 2005 Nov; 92(2):109-15. PubMed ID: 16231369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
    Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of mutS homolog 2 and mutL homolog 1 affects overall survival in laryngeal squamous cell carcinoma patients: Investigation into a potential cause.
    Gong HL; Shi Y; Shi Y; Wu CP; Cao PY; Zhou L; Xu C
    Oncol Rep; 2013 Sep; 30(3):1371-9. PubMed ID: 23787767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exonic deletions of mismatch repair genes MLH1 and MSH2 correlate with prognosis and protein expression levels in malignant melanomas.
    Korabiowska M; Brinck U; Stachura J; Jawien J; Hasse FM; Cordon-Cardos C; Fischer G
    Anticancer Res; 2006; 26(2A):1231-5. PubMed ID: 16619529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced detection of microsatellite instability and mismatch repair gene expression in cutaneous squamous cell carcinomas.
    Gray SE; Kay EW; Leader M; Mabruk MJ
    Mol Diagn Ther; 2006; 10(5):327-34. PubMed ID: 17022696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers.
    Kishi K; Doki Y; Yano M; Yasuda T; Fujiwara Y; Takiguchi S; Kim S; Higuchi I; Monden M
    Clin Cancer Res; 2003 Oct; 9(12):4368-75. PubMed ID: 14555508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of MutL homologue MLH1 and MutS homologue MSH2 expression in Turkish patients with sporadic colorectal cancer.
    Erdamar S; Ucaryilmaz E; Demir G; Karahasanoglu T; Dogusoy G; Dirican A; Goksel S
    World J Gastroenterol; 2007 Sep; 13(33):4437-44. PubMed ID: 17724798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
    Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
    Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    J Oral Pathol Med; 2011 Mar; 40(3):218-26. PubMed ID: 21029181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
    Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
    Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients.
    Lanza G; Gafà R; Santini A; Maestri I; Guerzoni L; Cavazzini L
    J Clin Oncol; 2006 May; 24(15):2359-67. PubMed ID: 16710035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
    Ohrling K; Edler D; Hallström M; Ragnhammar P
    Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of DNA repair genes MLH1 and MSH2 in adenocarcinomas and squamous cell carcinomas of the lung.
    Gomes A; Reis-Silva M; Alarcão A; Couceiro P; Sousa V; Carvalho L
    Rev Port Pneumol; 2014; 20(1):20-30. PubMed ID: 24360395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
    Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
    Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
    Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining.
    Mangold E; Pagenstecher C; Friedl W; Fischer HP; Merkelbach-Bruse S; Ohlendorf M; Friedrichs N; Aretz S; Buettner R; Propping P; Mathiak M
    J Pathol; 2005 Dec; 207(4):385-95. PubMed ID: 16216036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of DNA mismatch repair proteins and MSH2 polymorphisms in nonmelanoma skin cancers of organ transplant recipients.
    Perrett CM; Harwood CA; McGregor JM; Warwick J; Cerio R; Karran P
    Br J Dermatol; 2010 Apr; 162(4):732-42. PubMed ID: 19818066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.